{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:15:08Z","timestamp":1782476108902,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2377-13-188","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T16:14:10Z","timestamp":1386087250000},"source":"Crossref","is-referenced-by-count":25,"title":["The ReSPonD trial - rivastigmine to stabilise gait in Parkinson\u2019s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson\u2019s disease who have fallen"],"prefix":"10.1186","volume":"13","author":[{"given":"Emily J","family":"Henderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline CT","family":"Close","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Whone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Ben-Shlomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,3]]},"reference":[{"key":"924_CR1","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/01.wnl.0000313835.33830.80","volume":"70","author":"D Muslimovic","year":"2008","unstructured":"Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ: Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008, 70: 2241-2247. 10.1212\/01.wnl.0000313835.33830.80.","journal-title":"Neurology"},{"key":"924_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/geront\/42.6.790","volume":"42","author":"M Schenkman","year":"2002","unstructured":"Schenkman M, Cutson TM, Zhu CW, Whetten-Goldstein K: A longitudinal evaluation of patients\u2019 perceptions of Parkinson\u2019s disease. Gerontologist. 2002, 42: 790-798. 10.1093\/geront\/42.6.790.","journal-title":"Gerontologist"},{"key":"924_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/ageing\/afh203","volume":"34","author":"RW Genever","year":"2005","unstructured":"Genever RW, Downes TW, Medcalf P: Fracture rates in Parkinson\u2019s disease compared with age- and gender-matched controls: a retrospective cohort study. Age Ageing. 2005, 34: 21-24. 10.1093\/ageing\/afh203.","journal-title":"Age Ageing"},{"key":"924_CR4","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00415-009-5184-5","volume":"256","author":"MKY Mak","year":"2009","unstructured":"Mak MKY, Pang MYC: Fear of falling is independently associated with recurrent falls in patients with Parkinson\u2019s disease: a 1-year prospective study. J Neurol. 2009, 256: 1689-1695. 10.1007\/s00415-009-5184-5.","journal-title":"J Neurol"},{"key":"924_CR5","first-page":"300","volume":"67","author":"MA Hely","year":"1999","unstructured":"Hely MA, Morris JGL, Traficante R, Reid WGJ, Sullivan DJO, Williamson PM: The Sydney multicentre study of Parkinson\u2019 s disease: progression and mortality at 10 years. J Neurol. 1999, 67: 300-307.","journal-title":"J Neurol"},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.parkreldis.2005.06.011","volume":"12","author":"A Schrag","year":"2006","unstructured":"Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M: Caregiver-burden in parkinson\u2019s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006, 12: 35-41.","journal-title":"Parkinsonism Relat Disord"},{"key":"924_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/1531-8257(199911)14:6<947::AID-MDS1006>3.0.CO;2-O","volume":"14","author":"GK Wenning","year":"1999","unstructured":"Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I: Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord. 1999, 14: 947-950. 10.1002\/1531-8257(199911)14:6<947::AID-MDS1006>3.0.CO;2-O.","journal-title":"Mov Disord"},{"key":"924_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s004150200032","volume":"249","author":"A Schrag","year":"2002","unstructured":"Schrag A, Ben-Shlomo Y, Quinn N: How common are complications of Parkinson\u2019s disease?. J Neurol. 2002, 249: 419-423. 10.1007\/s004150200032.","journal-title":"J Neurol"},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM: Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007, 68: 384-386. 10.1212\/01.wnl.0000247740.47667.03.","journal-title":"Neurology"},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/mds.21598","volume":"22","author":"RM Pickering","year":"2007","unstructured":"Pickering RM, Grimbergen YAM, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, Bloem BR: A meta-analysis of six prospective studies of falling in Parkinson\u2019s disease. Mov Disord. 2007, 22: 1892-1900. 10.1002\/mds.21598.","journal-title":"Mov Disord"},{"key":"924_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL: The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord. 2008, 23: 837-844. 10.1002\/mds.21956.","journal-title":"Mov Disord"},{"key":"924_CR12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s00415-005-0855-3","volume":"252","author":"Y Balash","year":"2005","unstructured":"Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N: Falls in outpatients with Parkinson\u2019s disease: frequency, impact and identifying factors. J Neurol. 2005, 252: 1310-1315. 10.1007\/s00415-005-0855-3.","journal-title":"J Neurol"},{"key":"924_CR13","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/mds.23219","volume":"25","author":"IC L\u00f3pez","year":"2010","unstructured":"L\u00f3pez IC, Ruiz PJG, Del Pozo SVF, Bernardos VS: Motor complications in Parkinson\u2019s disease: ten year follow-up study. Mov Disord. 2010, 25: 2735-2739. 10.1002\/mds.23219.","journal-title":"Mov Disord"},{"key":"924_CR14","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI42642","volume":"120","author":"C Karachi","year":"2010","unstructured":"Karachi C, Grabli D, Bernard FA, Tande D, Wattiez N, Belaid H, Bardinet E, Prigent A, Nothacker H-P, Hunot S, Hartmann A, Lehericy S, Hirsch EC, Francois C: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest. 2010, 120: 2745-2754. 10.1172\/JCI42642.","journal-title":"J Clin Invest"},{"issue":"20","key":"924_CR15","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","volume":"73","author":"NI Bohnen","year":"2009","unstructured":"Bohnen NI, Muller MLTM, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL: History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 2009, 73 (20): 1670-1676. 10.1212\/WNL.0b013e3181c1ded6.","journal-title":"Neurology"},{"key":"924_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.parkreldis.2008.01.006","volume":"14","author":"JO Rinne","year":"2008","unstructured":"Rinne JO, Ma SY, Lee MS, Collan Y, R\u00f6ytt\u00e4 M: Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson\u2019s disease is related to disability of the patients. Parkinsonism Relat Disord. 2008, 14: 553-557. 10.1016\/j.parkreldis.2008.01.006.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"924_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00002093-199501002-00008","volume":"9","author":"AD Lawrence","year":"1995","unstructured":"Lawrence AD, Sahakian BJ: Alzheimer disease, attention, and the cholinergic system. Alzheimer Dis Assoc Disord. 1995, 9 (2): 37-49.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"924_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M: Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012, 27: 349-356. 10.1002\/mds.24893.","journal-title":"Mov Disord"},{"issue":"5","key":"924_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.410150503","volume":"15","author":"I Nakano","year":"2004","unstructured":"Nakano I, Hirano A: Parkinson\u2019s disease: neuron loss in the nucleus basalis without concomitant Alzheimer\u2019s disease. Ann Neurol. 2004, 15 (5): 415-418.","journal-title":"Ann Neurol"},{"key":"924_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2006.05.002","volume":"248","author":"K Jellinger","year":"2006","unstructured":"Jellinger K: The morphological basis of mental dysfunction in Parkinson\u2019s disease. J Neurol Sci. 2006, 248: 167-172. 10.1016\/j.jns.2006.05.002.","journal-title":"J Neurol Sci"},{"key":"924_CR21","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","volume":"65","author":"R Hilker","year":"2005","unstructured":"Hilker R, Thomas A, Klein J: Dementia in Parkinson disease functional imaging of cholinergic and dopaminergic pathways. Neurology. 2005, 65: 1716-1722. 10.1212\/01.wnl.0000191154.78131.f6.","journal-title":"Neurology"},{"key":"924_CR22","volume-title":"Attention and effort, Volume 88","author":"D Kahneman","year":"1973","unstructured":"Kahneman D: Attention and effort, Volume 88. 1973, Englewood Cliffs, NJ: Prentice-Hall"},{"key":"924_CR23","first-page":"918719","volume":"2012","author":"V Kelly","year":"2012","unstructured":"Kelly V, Eusterbrock A, Shumway-Cook A: A review of dual-task walking deficits in people with Parkinson\u2019s disease: motor and cognitive contributions, mechanisms, and clinical implications. Park Dis. 2012, 2012: 918719-","journal-title":"Park Dis"},{"key":"924_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jns.2006.05.010","volume":"248","author":"BR Bloem","year":"2006","unstructured":"Bloem BR, Grimbergen YAM, van Dijk JG, Munneke M: The \u201cposture second\u201d strategy: a review of wrong priorities in Parkinson\u2019s disease. J Neurol Sci. 2006, 248: 196-204. 10.1016\/j.jns.2006.05.010.","journal-title":"J Neurol Sci"},{"key":"924_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1532-5415.2009.02085.x","volume":"57","author":"M Montero-Odasso","year":"2009","unstructured":"Montero-Odasso M: Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc. 2009, 57: 359-360. 10.1111\/j.1532-5415.2009.02085.x.","journal-title":"J Am Geriatr Soc"},{"key":"924_CR26","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1532-5415.2008.01657.x","volume":"56","author":"F Assal","year":"2008","unstructured":"Assal F, Allali G: Galantamine improves gait performance in patients with Alzheimer\u2019s disease. J Am Geriatr Soc. 2008, 56: 946-947. 10.1111\/j.1532-5415.2008.01657.x.","journal-title":"J Am Geriatr Soc"},{"key":"924_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1212\/WNL.0b013e3181f6128c","volume":"75","author":"KA Chung","year":"2010","unstructured":"Chung KA, Lobb BM, Nutt JG, Horak FB: Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010, 75: 1263-1269. 10.1212\/WNL.0b013e3181f6128c.","journal-title":"Neurology"},{"key":"924_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2377-9-42","volume":"9","author":"M Montero-Odasso","year":"2009","unstructured":"Montero-Odasso M, Wells JL, Borrie MJ, Speechley M: Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial. BMC Neurol. 2009, 9: 42-10.1186\/1471-2377-9-42.","journal-title":"BMC Neurol"},{"key":"924_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E: FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008, 19: 385-397. 10.1007\/s00198-007-0543-5.","journal-title":"Osteoporos Int"},{"key":"924_CR30","doi-asserted-by":"publisher","first-page":"e3427","DOI":"10.1136\/bmj.e3427","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C: Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ. 2012, 344: e3427-10.1136\/bmj.e3427.","journal-title":"BMJ"},{"key":"924_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, Macknight C, Bergman H, Hogan DB, Mcdowell I, Mitnitski A: A global clinical measure of fitness and frailty in elderly people. Can Med J. 2005, 173: 489-495. 10.1503\/cmaj.050051.","journal-title":"Can Med J"},{"key":"924_CR32","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001, 56: M146-M157. 10.1093\/gerona\/56.3.M146.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"924_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0895-4356(93)90053-4","volume":"46","author":"R Washburn","year":"1993","unstructured":"Washburn R, Smith K, Jette A, Janney C: The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993, 46: 153-162. 10.1016\/0895-4356(93)90053-4.","journal-title":"J Clin Epidemiol"},{"key":"924_CR34","first-page":"67","volume":"69","author":"A Schrag","year":"2000","unstructured":"Schrag A, Selai C: The EQ-5D\u2014a generic quality of life measure\u2014is a useful instrument to measure quality of life in patients with Parkinson\u2019s disease. J Neurol. 2000, 69: 67-73.","journal-title":"J Neurol"},{"key":"924_CR35","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/mds.23362","volume":"25","author":"KL Chou","year":"2010","unstructured":"Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tr\u00f6ster AI, Uc EY: A recommended scale for cognitive screening in clinical trials of Parkinson\u2019s disease. Mov Disord. 2010, 25: 2501-2507. 10.1002\/mds.23362.","journal-title":"Mov Disord"},{"key":"924_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.2044-8260.1982.tb01421.x","volume":"21","author":"DE Broadbent","year":"1982","unstructured":"Broadbent DE, Cooper PF, FitzGerald P, Parkes KR: The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982, 21: 1-16. 10.1111\/j.2044-8260.1982.tb01421.x.","journal-title":"Br J Clin Psychol"},{"key":"924_CR37","doi-asserted-by":"publisher","first-page":"b2030","DOI":"10.1136\/bmj.b2030","volume":"338","author":"J Brown","year":"2009","unstructured":"Brown J, Pengas G, Dawson K: Self administered cognitive screening test (TYM) for detection of Alzheimer\u2019s disease: cross sectional study. BMJ. 2009, 338: b2030-10.1136\/bmj.b2030.","journal-title":"BMJ"},{"issue":"11","key":"924_CR38","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB A frontal assessment battery at bedside. Neurology. 2000, 55 (11): 1621-1626. 10.1212\/WNL.55.11.1621.","journal-title":"Neurology"},{"key":"924_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ageing\/28.1.35","volume":"28","author":"J Meara","year":"1999","unstructured":"Meara J, Mitchelmore E, Hobson P: GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson\u2019s disease and their carers in the community. Age Ageing. 1999, 28: 35-38. 10.1093\/ageing\/28.1.35.","journal-title":"Age Ageing"},{"key":"924_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.gaitpost.2009.07.108","volume":"30","author":"A Nieuwboer","year":"2009","unstructured":"Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE, Thomaes T, Giladi N: Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson\u2019s disease and their carers. Gait Posture. 2009, 30: 459-463. 10.1016\/j.gaitpost.2009.07.108.","journal-title":"Gait Posture"},{"issue":"March","key":"924_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0003-9993(96)90103-3","volume":"77","author":"S Lord","year":"1996","unstructured":"Lord S, Ward J, Williams P: Exercise effect on dynamic stability in older women: a randomized controlled trial. Arch Phys Med Rehabil. 1996, 77 (March): 232-236.","journal-title":"Arch Phys Med Rehabil"},{"key":"924_CR42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ptj\/83.3.237","volume":"83","author":"S Lord","year":"2003","unstructured":"Lord S, Menz H, Tiedemann A: A physiological profile approach to falls risk assessment and prevention. Phys Ther. 2003, 83: 237-252.","journal-title":"Phys Ther"},{"key":"924_CR43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/mds.25404","volume":"28","author":"SS Paul","year":"2013","unstructured":"Paul SS, Canning CG, Sherrington C, Lord SR, Close JCT, Fung VSC: Three simple clinical tests to accurately predict falls in people with Parkinson\u2019s disease. Mov Disord. 2013, 28: 655-662. 10.1002\/mds.25404.","journal-title":"Mov Disord"},{"key":"924_CR44","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N: Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008, 23: 2129-2170. 10.1002\/mds.22340.","journal-title":"Mov Disord"},{"key":"924_CR45","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"M Emre","year":"2004","unstructured":"Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin SLR: Rivastigmine for dementia associated with Parkinson\u2019s disease. N Engl J Med. 2004, 351: 2509-2518. 10.1056\/NEJMoa041470.","journal-title":"N Engl J Med"},{"key":"924_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1474-4422(07)70109-6","volume":"6","author":"HH Feldman","year":"2007","unstructured":"Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo J-M, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R: Effect of rivastigmine on delay to diagnosis of Alzheimer\u2019s disease from mild cognitive impairment: the InDDEx study. Lancet Neurol. 2007, 6: 501-512. 10.1016\/S1474-4422(07)70109-6.","journal-title":"Lancet Neurol"},{"key":"924_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1743-0003-2-19","volume":"2","author":"JM Hausdorff","year":"2005","unstructured":"Hausdorff JM: Gait variability : methods, modeling and meaning. J Neuroeng Rehabil. 2005, 2: 19-10.1186\/1743-0003-2-19.","journal-title":"J Neuroeng Rehabil"},{"key":"924_CR48","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/mds.22561","volume":"24","author":"MD Latt","year":"2009","unstructured":"Latt MD, Lord SR, Morris JGL, Fung VSC: Clinical and physiological assessments for elucidating falls risk in Parkinson\u2019s disease. Mov Disord. 2009, 24: 1280-1289. 10.1002\/mds.22561.","journal-title":"Mov Disord"},{"key":"924_CR49","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","volume":"75","author":"JC Dalrymple-Alford","year":"2010","unstructured":"Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ: The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010, 75: 1717-1725. 10.1212\/WNL.0b013e3181fc29c9.","journal-title":"Neurology"},{"key":"924_CR50","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/gerona\/glr019","volume":"66","author":"K Delbaere","year":"2011","unstructured":"Delbaere K, Smith ST, Lord SR: Development and initial validation of the iconographical falls efficacy scale. J Gerontol A Biol Sci Med Sci. 2011, 66: 674-680.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"924_CR51","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1532-5415.2005.53455.x","volume":"53","author":"SE Lamb","year":"2005","unstructured":"Lamb SE, J\u00f8rstad-Stein EC, Hauer K, Becker C: Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc. 2005, 53: 1618-1622. 10.1111\/j.1532-5415.2005.53455.x.","journal-title":"J Am Geriatr Soc"},{"key":"924_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1532-5415.1997.tb00946.x","volume":"45","author":"BE Maki","year":"1997","unstructured":"Maki BE: Gait changes in older adults: predictors of falls or indicators of fear. J Am Geriatr Soc. 1997, 45: 313-320.","journal-title":"J Am Geriatr Soc"},{"key":"924_CR53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/0891988702250580","volume":"16","author":"JM Hausdorff","year":"2003","unstructured":"Hausdorff JM, Balash J, Giladi N: Effects of cognitive challenge on Gait variability in patients with Parkinson\u2019s disease. J Geriatr Psychiatry Neurol. 2003, 16: 53-58.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"924_CR54","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/gerona\/60.4.530","volume":"60","author":"MC Robertson","year":"2005","unstructured":"Robertson MC, Campbell AJ, Herbison P: Statistical analysis of efficacy in falls prevention trials. J Gerontol A Biol Sci Med Sci. 2005, 60: 530-534. 10.1093\/gerona\/60.4.530.","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-13-188\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T08:08:43Z","timestamp":1597133323000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-13-188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-13-188","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"188"}}